---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-062800"
form_type: "8-K"
ticker: "ADIL"
cik: "0001513525"
company_name: "ADIAL PHARMACEUTICALS, INC."
filed_at: "2025-07-10T23:59:59+00:00"
generated_at: "2026-05-18T08:43:57.229231+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Adial Pharmaceuticals regains Nasdaq equity compliance after $3.6M offering

## Summary
- Received Nasdaq deficiency notice on May 23, 2025 for stockholders' equity of $2,126,662, below $2.5M minimum.
- Completed June 18, 2025 offering raising ~$3.6M gross via shares and warrants at $0.3251 per unit.
- Company believes it has now regained compliance with Nasdaq stockholders' equity requirement.
- Nasdaq will continue to monitor compliance; further non-compliance could lead to delisting.

## SEC filing metadata
- accession: 0001213900-25-062800
- form_type: 8-K
- ticker: ADIL
- cik: 0001513525
- company_name: ADIAL PHARMACEUTICALS, INC.
- filed_at: 2025-07-10T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1513525/000121390025062800/0001213900-25-062800-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1513525/000121390025062800/ea0248566-8k_adial.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-062800
- JSON: https://secwatch.observer/filing/0001213900-25-062800.json
- Plain text: https://secwatch.observer/filing/0001213900-25-062800.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.